In a reversal of fortune, yesterday (9 April) the UK Court of Appeal awarded AstraZeneca (AZ) an interim injunction keeping Glenmark’s dapagliflozin (dapa) off the UK market until the form of ...

Biocon and Glenmark are recalling anxiety and high cholesterol medications from US market due to manufacturing concerns, according to the U.S. Food and Drug Administration (USFDA). New Jersey-based ...

Glenmark Pharma is down 9 per cent for the week month period and 14 per cent year-to-date. Sun Pharma has fallen 3.63 per cent in the past one week; Zydus Lifesciences has declined 5.23 per cent ...

IPCA Laboratories, Glenmark Pharma and Biocon BION.NS were the top losers by percentage on the pharma index in Mumbai, ending the trading session between 4 per cent and 5.5 per cent lower.

Glenmark and Biocon are recalling products in the U.S. due to manufacturing issues. Glenmark is recalling 8,160 bottles of chlorpromazine hydrochloride for Nitrosamine impurity concerns, while Biocon ...

Glenmark and Biocon, two pharmaceutical companies, are recalling certain medications in the US due to manufacturing issues. The USFDA reports Glenmark is recalling Chlorpromazine for impurity issues, ...

Shares of Glenmark Pharmaceuticals Ltd. fell as much as 7% on Wednesday, April 9, after the US Food and Drug Administration (FDA) announced a Class-II recall of 39 drugs from the company's US arm. The ...

ProPublica is a nonprofit newsroom that investigates abuses of power. This piece was originally published in Dispatches, a newsletter that spotlights wrongdoing around the country. Sign up to ...

Glenmark's marketing portfolio as of December 2024 had 201 generic products authorised for distribution in the US. The company has 51 applications pending at various stages in the approval process.

US drugmakers' shares drop 3% to 6% premarket European, Indian healthcare stocks drag down broader indexes Trump aims to shift pharma manufacturing to US, but analysts doubtful April 9 (Reuters ...

After two weeks of rallies, Indian equity indices closed sharply lower this week with the NIFTY down by 615 points and the Sensex down by 2,050 points. The downturn was triggered by US president ...